- Home
- URG vs BNTC Comparison
URG vs BNTC Comparison
Compare URG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | URG | BNTC |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.9M | 405.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | URG | BNTC |
|---|---|---|
| Price | $1.53 | $12.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $2.52 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 13.0M | 270.9K |
| Earning Date | 11-03-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,411,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $183.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 138.94 | N/A |
| 52 Week Low | $0.55 | $9.70 |
| 52 Week High | $2.35 | $17.15 |
Technical Indicators
Market Signals| Indicator | URG | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 62.19 | 45.35 |
| Support Level | $1.28 | $10.99 |
| Resistance Level | $1.45 | $14.39 |
| Average True Range (ATR) | 0.08 | 1.09 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 92.19 | 53.59 |
Price Performance
Historical ComparisonAbout URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.